Pegylated interferon alpha-2A and ribavarin for the treatment of chronic Hepatitis C.
PK140984AUndetermined Publication Date: 2010-10-27F HOFFMANN LA ROCHE & CO AG
0 Cites 0 Cited by
Patent Information
- Application Number
- PK199900470
- Authority / Receiving Office
- PK · PK
- Patent Type
- Applications
- Current Assignee / Owner
- Publication Date
- 2010-10-27
Abstract
The present invention provides the use of PEG-IFN-α conjugates in association with Ribavirin for the manufacture of medicaments for the treatment of chronic hepatitis C infections. The present invention also provides a method for treating chronic hepatitis C infections in patients in need of such treating comprising administering an amount of PEG-IFN-α conjugate in association with an amount of Ribavirin effective to treat hepatitis C.
Need to check novelty before this filing date? Find Prior Art